From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
February 25, 2025 at 1PM EST
The Medicare drug price negotiation component of the Inflation Reduction Act represents a watershed moment for pharmaceutical pricing in the U.S., with far-reaching implications for drug development, market access, and industry strategy. The implications of this program are reshaping investment decisions and impacting pricing and market access strategies for new and existing drugs. The pharmaceutical industry is actively adapting its approach to portfolio management and market access planning in response to this evolving landscape. Join us as we explore recent developments in this space and review considerations for manufacturers:
In this webinar, we will delve into the key aspects of the IRA, including:
Join us for this timely and informative webinar as we navigate the challenges and opportunities presented by this transformative legislation.
Bharat LakshminarayananExecutive Director, Advisory Services
Jeff BaabPartner, Advisory Services